Ground-breaking HF trial with evidence for SGLT2i at EF>40% - PACE-CME

Groundbreaking HF trial with evidence for SGLTi at EF

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Implementation of salt substitution strategies
Implementation of salt substitution strategies
ESC 2021
Implementation of salt substitution strategies
- Prof. Barbara Casadei, MD
Surgery vs. stenting with asymptomatic critical carotid artery stenosis
Surgery vs. stenting with asymptomatic critical carotid artery stenosis
ESC 2021
Surgery vs. stenting with asymptomatic critical carotid artery stenosis
- Prof. Freek Verheugt, MD
Switching to a salt substitute reduces risk of stroke, CV events and death
Switching to a salt substitute reduces risk of stroke, CV events and death
ESC 2021
Switching to a salt substitute reduces risk of stroke, CV events and death
- Prof. Bruce Neal, MD, PhD
Non-steroidal MRA effective in reducing CV events in patients with diabetes and CKD
Non-steroidal MRA effective in reducing CV events in patients with diabetes and CKD
ESC 2021
Non-steroidal MRA effective in reducing CV events in patients with diabetes and CKD
- Prof Bertram Pitt